Pregnancy-associated plasma protein levels at term in normal pregnancy, preeclampsia and essential hypertension

Related Experiment Video

Updated: Oct 12, 2026

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
12:02

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption

Published on: July 30, 2016

J F Griffin

    The Australian & New Zealand Journal of Obstetrics & Gynaecology
    |February 1, 1983
    PubMed

    Insights

    Reduced levels of pregnancy-associated alpha 2-globulin (alpha 2-PAG) may indicate preeclampsia risk. Elevated ceruloplasmin suggests a general inflammatory response in hypertensive pregnancies.

    Area of Science:

    • Biochemistry
    • Obstetrics
    • Immunology

    Background:

    • Pregnancy involves complex physiological changes affecting various protein levels.
    • Specific proteins like SP1, alpha 2-PAG, C3c, and ceruloplasmin are linked to pregnancy status, immune function, and inflammation.

    Purpose of the Study:

    • To investigate the levels of pregnancy-associated proteins (SP1, alpha 2-PAG), complement (C3c), and inflammation markers (ceruloplasmin) in normal and complicated pregnancies.
    • To determine if these protein levels have prognostic value or are associated with the etiology of preeclampsia and hypertension.

    Main Methods:

    • Protein levels (SP1, alpha 2-PAG, C3c, ceruloplasmin) were measured in blood samples from pregnant women at term.
    • Patients were categorized into groups based on parity (primigravid/multigravid) and pregnancy complications (normal, preeclampsia, essential hypertension).
    • Statistical analysis was performed to compare protein levels between different patient groups.

    Main Results:

    • Levels of SP1 and C3c were comparable across all studied groups.
    • Significantly lower alpha 2-PAG levels were observed in preeclamptic primigravidas and multigravidas with a history of preeclampsia.
    • Ceruloplasmin levels were significantly elevated in patients with preeclampsia and essential hypertension.

    Conclusions:

    • Reduced plasma alpha 2-PAG may serve as a prognostic indicator for preeclampsia and potentially play a role in its development.
    • Elevated ceruloplasmin levels likely represent an acute phase reaction to hypertensive pathologies rather than a specific marker for preeclampsia etiology.

    More Related Videos

    The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo12:17

    The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

    Published on: August 2, 2017

    Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas05:31

    Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

    Published on: January 26, 2024

    Related Concept Videos

    Hormonal Regulation01:33

    Hormonal Regulation

    The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
    Teratogenicity01:07

    Teratogenicity

    The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

    Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
    These markers indicate stress or strain on the heart muscle:
    Natriuretic Peptides (BNP)
    Cardiac myocytes produce these hormones in response to ventricular stretching...
    Mitral Valve Prolapse III: Nursing Management01:19

    Mitral Valve Prolapse III: Nursing Management

    The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
    Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

    Hypertension III: Clinical Manifestations and Diagnostic Studies

    Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
    Nephrotic Syndrome II : Assessment and Medical Management01:26

    Nephrotic Syndrome II : Assessment and Medical Management

    IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...